Delcath Systems (DCTH) EBITDA Margin Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Delcath Systems | 383.27 Mn | 293.95 Mn | 21.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 254,475.00 |
| Dec 31, 2025 | 88,525.00 |
| Sep 30, 2025 | 404,827.00 |
| Jun 30, 2025 | 164,410.00 |
| Mar 31, 2025 | 661,369.00 |
| Dec 31, 2024 | -221,832.00 |
| Sep 30, 2024 | 454,716.00 |
| Jun 30, 2024 | 295,308.00 |
| Mar 31, 2024 | 400,007.00 |
| Dec 31, 2023 | -249,392.00 |
| Sep 30, 2023 | -362,056.00 |
| Jun 30, 2023 | -67,476.00 |
| Mar 31, 2023 | -252,330.00 |
| Dec 31, 2022 | 142,554.00 |
| Sep 30, 2022 | 85,883.00 |
| Jun 30, 2022 | -94,070.00 |
| Mar 31, 2022 | -85,229.00 |
| Dec 31, 2021 | 104,616.00 |
| Sep 30, 2021 | -533,881.00 |
| Jun 30, 2021 | -32,601.00 |
| Mar 31, 2021 | -206,120.00 |
| Dec 31, 2020 | 26,793.00 |
| Sep 30, 2020 | -343,484.00 |
| Jun 30, 2020 | -83,979.00 |
| Mar 31, 2020 | -581,804.00 |
| Dec 31, 2019 | 322,516.00 |
| Sep 30, 2019 | -242,726.00 |
| Jun 30, 2019 | -129,130.00 |
| Mar 31, 2019 | -265,011.00 |
| Dec 31, 2018 | 126,574.00 |
| Sep 30, 2018 | 892,257.00 |
| Mar 31, 2018 | 1.64 Mn |
| Dec 31, 2017 | 262,927.00 |
| Sep 30, 2017 | 2.82 Mn |
| Jun 30, 2017 | 1.34 Mn |